Compare COFS & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | CERS |
|---|---|---|
| Founded | 1898 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.9M | 465.5M |
| IPO Year | 1995 | 1996 |
| Metric | COFS | CERS |
|---|---|---|
| Price | $34.24 | $2.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $37.00 | $5.13 |
| AVG Volume (30 Days) | 77.7K | ★ 1.7M |
| Earning Date | 11-10-2026 | 11-02-2026 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | N/A | ★ 27.27 |
| EPS | ★ 1.74 | N/A |
| Revenue | ★ $227,624,000.00 | $51,326,000.00 |
| Revenue This Year | $8.11 | $20.82 |
| Revenue Next Year | $3.72 | $9.02 |
| P/E Ratio | $19.97 | ★ N/A |
| Revenue Growth | ★ 63.64 | 30.68 |
| 52 Week Low | $26.63 | $1.38 |
| 52 Week High | $35.00 | $3.47 |
| Indicator | COFS | CERS |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 55.18 |
| Support Level | $32.18 | $2.37 |
| Resistance Level | $34.93 | $3.12 |
| Average True Range (ATR) | 0.83 | 0.08 |
| MACD | 0.20 | 0.03 |
| Stochastic Oscillator | 70.94 | 89.19 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.